Stock Analysis
- China
- /
- Medical Equipment
- /
- SZSE:300595
Autek China First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Autek China (SZSE:300595) First Quarter 2024 Results
Key Financial Results
- Revenue: CN¥464.5m (up 16% from 1Q 2023).
- Net income: CN¥193.0m (up 11% from 1Q 2023).
- Profit margin: 42% (down from 43% in 1Q 2023). The decrease in margin was driven by higher expenses.
- EPS: CN¥0.22 (up from CN¥0.19 in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Autek China EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 9.2%. Earnings per share (EPS) exceeded analyst estimates by 1.1%.
Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Medical Equipment industry in China.
Performance of the Chinese Medical Equipment industry.
The company's shares are up 7.6% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Autek China that you should be aware of.
Valuation is complex, but we're helping make it simple.
Find out whether Autek China is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:300595
Autek China
Autek China Inc. provides eye health and myopia prevention, and control technology and services in China.
Excellent balance sheet and fair value.